These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 23416067)

  • 1. BH3 mimetics reduce adhesion and migration of hepatoblastoma and hepatocellular carcinoma cells.
    Vogt F; Lieber J; Dewerth A; Hoh A; Fuchs J; Armeanu-Ebinger S
    Exp Cell Res; 2013 Jun; 319(10):1443-50. PubMed ID: 23416067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BH3-mimetic drugs prevent tumour onset in an orthotopic mouse model of hepatoblastoma.
    Lieber J; Ellerkamp V; Vogt F; Wenz J; Warmann SW; Fuchs J; Armeanu-Ebinger S
    Exp Cell Res; 2014 Mar; 322(1):217-25. PubMed ID: 24355809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells.
    Lieber J; Kirchner B; Eicher C; Warmann SW; Seitz G; Fuchs J; Armeanu-Ebinger S
    Pediatr Blood Cancer; 2010 Dec; 55(6):1089-95. PubMed ID: 20680965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastoma.
    Lieber J; Armeanu-Ebinger S; Fuchs J
    Int J Mol Sci; 2015 Feb; 16(2):4190-208. PubMed ID: 25690034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased efficacy of CDDP in a xenograft model of hepatoblastoma using the apoptosis sensitizer ABT-737.
    Lieber J; Dewerth A; Wenz J; Kirchner B; Eicher C; Warmann SW; Fuchs J; Armeanu-Ebinger S
    Oncol Rep; 2013 Feb; 29(2):646-52. PubMed ID: 23229825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BH3 mimetic ABT-737 increases treatment efficiency of paclitaxel against hepatoblastoma.
    Lieber J; Eicher C; Wenz J; Kirchner B; Warmann SW; Fuchs J; Armeanu-Ebinger S
    BMC Cancer; 2011 Aug; 11():362. PubMed ID: 21854558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis sensitizers enhance cytotoxicity in hepatoblastoma cells.
    Lieber J; Ellerkamp V; Wenz J; Kirchner B; Warmann SW; Fuchs J; Armeanu-Ebinger S
    Pediatr Surg Int; 2012 Feb; 28(2):149-59. PubMed ID: 21971946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of in vitro antileukemic activity of obatoclax and ABT-737.
    Opydo-Chanek M; Mazur L
    Tumour Biol; 2016 Aug; 37(8):10839-49. PubMed ID: 26880588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib.
    Hikita H; Takehara T; Shimizu S; Kodama T; Shigekawa M; Iwase K; Hosui A; Miyagi T; Tatsumi T; Ishida H; Li W; Kanto T; Hiramatsu N; Hayashi N
    Hepatology; 2010 Oct; 52(4):1310-21. PubMed ID: 20799354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737.
    Lucas KM; Mohana-Kumaran N; Lau D; Zhang XD; Hersey P; Huang DC; Weninger W; Haass NK; Allen JD
    Clin Cancer Res; 2012 Feb; 18(3):783-95. PubMed ID: 22173547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell Death Induction by the Indirubin Derivative 7BIO and the BH3 Mimetic Drugs ABT-737 and GX15-070 in Medullary Thyroid Carcinoma Cells.
    Broecker-Preuss M; Becher-Boveleth N; Mann K
    Exp Clin Endocrinol Diabetes; 2016 May; 124(5):324-30. PubMed ID: 26849668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinoma.
    Galmiche A; Ezzoukhry Z; François C; Louandre C; Sabbagh C; Nguyen-Khac E; Descamps V; Trouillet N; Godin C; Regimbeau JM; Joly JP; Barbare JC; Duverlie G; Mazière JC; Chatelain D
    Mol Cancer Res; 2010 Aug; 8(8):1116-25. PubMed ID: 20647330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bcl-2 inhibitor ABT-737 enhances the cisplatin-induced apoptosis in breast cancer T47D cells].
    Chen ZJ; Zhang B; Pan SH; Zhao HM; Zhang Y; Feng WH; Li YY; Cao XC
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):891-5. PubMed ID: 22340096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of caspases-9, -3 and -8 in human platelets triggered by BH3-only mimetic ABT-737 and calcium ionophore A23187: caspase-8 is activated via bypass of the death receptors.
    Mutlu A; Gyulkhandanyan AV; Freedman J; Leytin V
    Br J Haematol; 2012 Dec; 159(5):565-71. PubMed ID: 23025479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BH3-mimetic ABT-737 induces mast cell apoptosis in vitro and in vivo: potential for therapeutics.
    Karlberg M; Ekoff M; Huang DC; Mustonen P; Harvima IT; Nilsson G
    J Immunol; 2010 Aug; 185(4):2555-62. PubMed ID: 20639495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance.
    Wroblewski D; Mijatov B; Mohana-Kumaran N; Lai F; Gallagher SJ; Haass NK; Zhang XD; Hersey P
    Carcinogenesis; 2013 Feb; 34(2):237-47. PubMed ID: 23087082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BH3 mimetics suppress CXCL12 expression in human malignant peripheral nerve sheath tumor cells.
    Graham CD; Kaza N; Pruitt HC; Gibson LM; Klocke BJ; Shevde LA; Carroll SL; Roth KA
    Oncotarget; 2017 Jan; 8(5):8670-8678. PubMed ID: 28055968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
    Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
    J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia.
    Mason KD; Khaw SL; Rayeroux KC; Chew E; Lee EF; Fairlie WD; Grigg AP; Seymour JF; Szer J; Huang DC; Roberts AW
    Leukemia; 2009 Nov; 23(11):2034-41. PubMed ID: 19641525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BH3-mimetic ABT-737 targets the apoptotic machinery in cholangiocarcinoma cell lines resulting in synergistic interactions with zoledronic acid.
    Romani AA; Desenzani S; Morganti MM; Baroni MC; Borghetti AF; Soliani P
    Cancer Chemother Pharmacol; 2011 Mar; 67(3):557-67. PubMed ID: 20473610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.